Chemokines (such as MCP-1), as a family of small cytokines, could be used as chemoattractants to guide cell migration, promote leukocyte infiltration into ischemic brain tissue, and enhance inflammatory response during cerebral ischemia-reperfusion (Wang Y. et al., 2013). The gene discussed is CCL2; the disease is brain ischemia.